Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.

By Allan L. Klein, Richard A. Grimm, R. Murray, C. Apperson-Hansen, R. Asinger, I. Black, Ravin Davidoff, R. Erbel, Jonathan L. Halperin, David A. Orsinelli and 2 more. New England Journal of Medicine, 2001

900 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/cfc47406f117442170792e998a6b5f5f0b098fcc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Gerhard Hindricks
2. Gregory Y. H. Lip
3. A. Goette
4. Paulus Kirchhof
5. Ulrich Schotten
6. Cynthia Rudin

Citations in the corpus

• Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). (2010, methodology): “A TOE-guided cardioversion strategy is recommended as an alternative to 3-week pre-cardioversion anticoagulation if experienced staff and appropriate facilities are available, and, when early cardioversion is needed, pre-cardioversion OAC is not indicated due to patient choice or potential bleeding ”
• 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016, neutral): “When early cardioversion is desired, TOE can exclude the majority of left atrial thrombi, allowing immediate cardioversion.(648,649) Ongoing studies will inform about the safety and efficacy of newly initiated anticoagulation using NOACs in patients scheduled for cardioversion.”